ERK 1/2 and p38 MAPK mediate the effect of BAPTA-AM inhibiting RANKL-induced bone marrow macrophages differentiation
XU Li-peng
Abstract
XU Li-peng
Abstract
Aim To explore whether ERK 1 /2 and p38 MAPK could mediate the effect of BAPTA-AM inhibiting RANKL-induced bone marrow macrophages differentiation.Methods BMMs were cultured with various concentrations of BAPTA-AM in the presence of MCSF(25 μg·L-1) and RANKL(25 μg·L-1) for 7 days,osteoclastogenic ability,osteoclast survival and the expression of phosphorylated ERK1 /2 and p38 MAPK were measured by TRAP staining and Western blot.Results BAPTA-AM inhibited osteoclastogenesis and osteoclast survival of BMMs by RANKL induction.The immunoblotting data revealed that BAPTA-AM could inhibit the phosphorylation of ERK1 /2 and p38 MAPK which were activated by RANKL.Conclusion ERK 1 /2 and p38 MAPK can mediate the effect of BAPTA-AM inhibiting osteoclastogenic ability of BMMs.This finding may be useful in the development of an osteoclastic inhibitor that targets intracellular signaling factors.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aim To explore whether ERK 1 /2 and p38 MAPK could mediate the effect of BAPTA-AM inhibiting RANKL-induced bone marrow macrophages differentiation.Methods BMMs were cultured with various concentrations of BAPTA-AM in the presence of MCSF(25 μg·L-1) and RANKL(25 μg·L-1) for 7 days,osteoclastogenic ability,osteoclast survival and the expression of phosphorylated ERK1 /2 and p38 MAPK were measured by TRAP staining and Western blot.Results BAPTA-AM inhibited osteoclastogenesis and osteoclast survival of BMMs by RANKL induction.The immunoblotting data revealed that BAPTA-AM could inhibit the phosphorylation of ERK1 /2 and p38 MAPK which were activated by RANKL.Conclusion ERK 1 /2 and p38 MAPK can mediate the effect of BAPTA-AM inhibiting osteoclastogenic ability of BMMs.This finding may be useful in the development of an osteoclastic inhibitor that targets intracellular signaling factors.
Key concepts: RANKL, Osteoclast, MAPK/ERK pathway, p38 mitogen-activated protein kinases, BAPTA, Chemistry, Cell biology, Bone marrow